Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ARXS
ARXS logo

ARXS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
39.240
Open
37.670
VWAP
38.21
Vol
3.82M
Mkt Cap
15.26B
Low
37.390
Amount
146.06M
EV/EBITDA(TTM)
--
Total Shares
401.57M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

(ET)
2026-04-16
12:30:00
Arxis Prices 40.5M Shares at $28.00
select
2026-04-16
05:00:00
Goldman Sachs and Others Price Deal at $28
select

News

renaissancecapital
8.5
04-17renaissancecapital
IPO Market Heats Up with $4.5 Billion Raised by Five Listings
  • Record Fundraising: This week, five companies raised a total of $4.5 billion in IPOs, including two deals exceeding $1 billion, highlighting a significant uptick in market activity, particularly with Madison Air Solutions leading at $2.233 billion, reflecting strong demand for indoor air quality technologies.
  • Strong Market Performance: Madison Air Solutions completed its IPO at the high end of pricing, achieving a market cap of $13.423 billion and a first-day return of 20%, indicating investor confidence in its air management technologies for data centers and commercial environments, which is expected to drive further market share growth.
  • Biotech Breakthrough: Kailera Therapeutics raised $625 million, setting a record for US biotech IPOs with a market cap of $2.021 billion, as its lead candidate is currently in global Phase 3 trials, showcasing its potential in obesity treatment, with a first-day return of 63%.
  • Growth in Defense Electronics: Arxis successfully raised $1.134 billion in its IPO, achieving a market cap of $11.633 billion; despite cyclical risks in aerospace and defense spending, its profitability and expanding free cash flow maintain its competitive edge, with a first-day return of 36%.
seekingalpha
8.5
04-16seekingalpha
Arxis Inc. Shares Surge 36% on Strong IPO Debut Raising $1.13 Billion
  • Strong IPO Performance: Arxis Inc. shares surged 36% on their first day of trading on Nasdaq, rising from the IPO price of $28 to $38, indicating robust investor demand for its $1.13 billion expanded IPO, valuing the company at approximately $15.4 billion.
  • Increased Offering Size: The company expanded its offering from the initially planned 37.7 million shares to 40.5 million shares, pricing at the top end of the $25 to $28 target range, reflecting strong market interest in the defense and aerospace sectors.
  • Diverse Business Structure: According to regulatory filings, defense and space applications account for 47% of Arxis's projected 2025 revenue, while commercial aerospace contributes 23%, highlighting the company's broad exposure to both military and civil aviation markets, allowing it to capitalize on rising global defense spending.
  • Positive Industry Trends: The listing of Arxis has attracted investor attention amid increasing global defense spending, particularly as U.S. policymakers are expected to prioritize the expansion and modernization of missile systems, further fueling investment enthusiasm for companies linked to military supply chains.
seekingalpha
8.5
04-16seekingalpha
Arxis Prices IPO at $28, Raising $1.13 Billion
  • IPO Financing Size: Arxis priced its IPO at $28 per share for 40.5 million shares, raising $1.13 billion, reflecting strong market confidence in its business model and providing ample funds for future expansion.
  • Market Positioning: Arxis focuses on aerospace, medical technology, and specialized industrial markets, designing and manufacturing critical electronic and mechanical engineering components, and the IPO will further solidify its market position in these high-growth sectors.
  • Acquisition Expansion Strategy: Under Arcline Investment Management's support, Arxis has rapidly expanded through over 30 acquisitions since 2019, including the $1.8 billion purchase of rival Kaman in 2024, enhancing its competitive edge in the industry.
  • Transaction Arrangements: The underwriters have a 30-day option to purchase an additional 6.075 million shares, potentially increasing the financing size, with shares expected to begin trading on Nasdaq on April 16, 2026, under the symbol 'ARXS'.
renaissancecapital
8.5
04-16renaissancecapital
Arxis Raises $1.1 Billion in Successful IPO at $28 per Share
  • Significant Fundraising: Arxis successfully raised $1.1 billion by offering 40.5 million shares at $28 each, exceeding its initial plan of 37.7 million shares, indicating strong market confidence in its business.
  • Cornerstone Investor Support: Key investors such as Capital Group, Janus Henderson Investors, and T. Rowe Price committed $400 million, representing 35% of the IPO, further solidifying market recognition of Arxis.
  • Diverse Product Line: Arxis specializes in electronic and mechanical components for high-performance environments, with products including connectors, sensors, and precision mechanical parts, widely used in aerospace, defense, and medical technology, showcasing its strategic positioning in multiple high-growth markets.
  • Acquisition Expansion Strategy: Since its formation in 2019, Arxis has completed 32 acquisitions, including Kaman Corporation, demonstrating its commitment and capability to accelerate market share growth through strategic acquisitions.
Wall Street analysts forecast ARXS stock price to rise
0 Analyst Rating
Wall Street analysts forecast ARXS stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for Arxis, Inc. (ARXS.O) is 0.00, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Arxis, Inc.'s fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
Current PE
0.00
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
Current PS
0.00
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding ARXS

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Arxis, Inc. (ARXS) stock price today?

The current price of ARXS is 38 USD — it has decreased -1.94

What is Arxis, Inc. (ARXS)'s business?

What is the price predicton of ARXS Stock?

Wall Street analysts forecast ARXS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARXS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Arxis, Inc. (ARXS)'s revenue for the last quarter?

Arxis, Inc. revenue for the last quarter amounts to NaN USD, decreased

What is Arxis, Inc. (ARXS)'s earnings per share (EPS) for the last quarter?

Arxis, Inc.. EPS for the last quarter amounts to USD, decreased

How many employees does Arxis, Inc. (ARXS). have?

Arxis, Inc. (ARXS) has 0 emplpoyees as of April 18 2026.

What is Arxis, Inc. (ARXS) market cap?

Today ARXS has the market capitalization of 15.26B USD.